Genmab
GMAB
$29.98
Share price
1.11%
Change (1 day)
-27.58%
Change (1 year)
Categories
Market capitalization of Genmab (GMAB)
Market cap: $19.36 Billion
As of May 2024 Genmab has a market cap of $19.36 Billion. This makes Genmab the world's 991th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Genmab from 2010 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $19.36 B | -6.9% |
| 2023 | $20.79 B | -25.6% |
| 2022 | $27.95 B | 6.75% |
| 2021 | $26.18 B | -1.86% |
| 2020 | $26.68 B | 85.08% |
| 2019 | $14.41 B | 43.77% |
| 2018 | $10.02 B | -0.52% |
| 2017 | $10.08 B | 0.47% |
| 2016 | $10.03 B | 25.41% |
| 2015 | $8.00 B | 138.74% |
| 2014 | $3.35 B | 65.01% |
| 2013 | $2.03 B | 192.75% |
| 2012 | $0.69 B | 136.2% |
| 2011 | $0.29 B | -51.56% |
| 2010 | $0.60 B |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Genmab was reported to be:
$19.36 Billion
$19.36 Billion
$19.80 Billion
$19.83 Billion